Weekly roundup: Clearance, Capital & Copenhagen: A week in review!
AMS announced its Interim results for the six months ended 30 June 2025
This week Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announced its unaudited interim results for the six months ended 30 June 2025. Group revenue increased by 63% to £110.8 million and by 66% at constant currency (2024 H1: £68.0 million) with organic growth supplemented by the impact of the Peters Surgical acquisition that completed 1st July 2024. Overall performance was in line with management expectations including a strong showing from the existing AMS business (excluding Peters) growing revenues by 13% and by 14% at constant currency.
Access the results presentation and replay linked here.
Amber Implants secured FDA 510(k) clearance for its VCFix® spinal system: a next-generation solution for vertebral compression fractures
Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, announced it has received clearance from the US Food and Drug Administration (FDA) for its VCFix® Spinal System. This clearance confirms the device’s safety and performance and represents a globally recognised validation of its clinical value, providing immediate access to the world’s largest MedTech market.
Resolution Therapeutics hosted a virtual R&D webinar
Resolution Therapeutics hosted a virtual R&D webinar alongside world leading clinical hepatologists Prof. Jonathan Fallowfield and Dr. Elliot Tapper. The event featured a comprehensive update on Resolution’s progress following its £63.5 million Series B financing, and MHRA and AEMPS approval for commencement of the Phase 1/2 EMERALD trial for RTX001 in the UK and Spain.
Access the full webinar replay linked here.
📺Optimum TV
Have you been watching Optimum TV’s mini-series Countdown to Conference? Ahead of Optimum’s 17th Annual Healthcare Investor Conference being held on Thursday October 9th at The King’s Fund in London – we talked to upcoming illustrious speakers on the agenda.
Episode 1: Guest Philip Brainin, Associate at Sound Bioventures discusses why junior VCs are vital to the industry, why he picked venture capital over being a doctor or pursuing academic research, and how we can better measure the true value of innovative medicines. Watch the episode here ⬇️
Episode 2: Seasoned life science investor Søren Møller, Managing Partner of Novo Holdings Seed Investments talks about the up-and-down year 2025 is proving to be for the life science market, how this has impacted investment decisions, and the importance of “ploughing on”. Watch the episode here
Episode 3: **COMING SOON** An excellent episode is in the can and due to release next week with heavy weight Antoine Papiernik managing Partner of Sofinnova Partners.
🔥Hot topic
This week’s Optimum ‘Hot Topic’ – Where is AI having the biggest impact in healthcare right now?
While there’s a huge amount of interest in how #AI could help find new drugs to cure diseases, proven success in this field remains some way off. However, other applications of AI are having a real impact at the coalface of #healthcare right now. Read our latest #HotTopic to learn more!
👥Industry events
Novo Holdings Seed Summit 2025
Yesterday, Optimum CEO, Mary Clark attended Seed Summit 2025, organised by the Seed Investments team at Novo Holdings, in Copenhagen! The annual invitation only event was once again packed with exciting #panels and great #networking opportunities.
Always a pleasure! Thanks to the Novo team for the invite and generous hospitality – check out the beautiful view from the reception held at the Opera House!
📢 Optimum’s 17th Annual Healthcare Conference
Final call for a place at Optimum’s 17th Annual Healthcare Investor Conference! The agenda is complete and what a stellar line up of speakers we have! Join us on 9th October at The King’s Fund, London, to hear from those that are shaping the markets and discover how to refine your narrative to attract the right investment – this is where science meets strategy. Register your interest in attending today
📅 Join us at the LSX Investival Showcase Europe 2025!
Two months countdown! On Monday 17th November at Old Billingsgate, London capital meets innovation, and global leaders come to connect, pitch, and partner.
Optimum is proud to be a supporting partner of the LSX Investival Showcase Europe. 👉 Learn more and register here!
